The Role of Biomarker Testing in Advanced NSCLC
- Amanda Bridges
- December 22, 2016
- News
In partnership with Boehringer Ingelheim, FLASCO is pleased to provide the following video on the importance of biomarker testing in NSCLC. Presented by Mohammad Jahanzeb, MD, FACP, Professor of Clinical Medicine & Hematology Oncology at University of Miami’s Miller School of Medicine, the video touches on the importance of biomarker testing, continuing the focus on the need for the multidisciplinary process and a streamlined approach for biopsy and diagnostic assessment. Please take a few minutes and watch this important video!